Zhang F#, Zhao D#, Wu YZ#, Li L*. Prenylated bacterial natural products: occurrence, chemical diversity, biosynthesis and bioactivity. Natural Product Reports 2025; doi: 10.1039/d5np00011d.
Zhang F#, Zhang F#, Yu XC#, Sun RZ, Wu YZ, Zhou YW, Li L*. Discovery of a novel family of Gram-negative-active cationic cyclolipopeptides by motif search-guided chemical synthesis. CCS Chemistry 2025; doi: 10.31635/ccschem.024.202404925.
Sun RZ#, Zhao D#, Yu XC#, Zhang F, You RX, Luo XX, Li L*. Discovery of a family of menaquinone-targeting cyclic lipodepsipeptides for multidrug-resistant Gram-positive pathogens. Communications Biology 2024; 7:1453.
Sun RZ, You RX, Yu XC, Zhao D, Li L*. Discovery and synthesis of a Gram-negative-active cationic lipopeptide antibiotic inspired by primary sequences from underexplored Gram-negative bacteria. Organic Letters 2024; 26:1348-1352.
Li L*. Accessing hidden microbial biosynthetic potential from underexplored sources for novel drug discovery. Biotechnology Advances 2023; 66:108176.
Li L, Wei KK, Liu XC, Wu YJ, Zheng GS, Chen SX, Jiang WH*, Lu YH*. aMSGE: advanced multiplex site-specific genome engineering with orthogonal modular recombinases in actinomycetes. Metabolic Engineering 2019; 52:153-167.
Li L, Liu XC, Wei KK, Lu YH*, Jiang WH*. Synthetic biology approaches for chromosomal integration of genes and pathways in industrial microbial systems. Biotechnology Advances 2019; 37(5):730-745.
Li L, Zheng GS, Chen J, Ge M, Jiang WH*, Lu YH*. Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes. Metabolic Engineering 2017; 40:80-92.